World's Best Scientists 2026 revealed!
Fumio Imazeki

Fumio Imazeki

D-Index & Metrics

Microbiology

D-Index
63
Citations
13718
World Ranking
2736
National Ranking
101

Overview

Fumio Imazeki is affiliated with Chiba University in Japan and specializes in medical research with a focus on several subfields including epidemiology, hepatology, pulmonary and respiratory medicine, oncology, and health toxicology and mutagenesis. Their research contributions span various aspects of liver diseases, viral infections, and public health impacts related to infectious diseases and environmental factors.

The main areas of study for Imazeki include medicine, with five publications contributing to this field. The specific subfields represented in their work are:

  • Epidemiology (2 publications)
  • Hepatology (1 publication)
  • Pulmonary and Respiratory Medicine (1 publication)
  • Oncology (1 publication)
  • Health, Toxicology and Mutagenesis (1 publication)

Their research topics cover a range of subjects related to infectious diseases, liver disease, and healthcare impacts, as follows:

  • Hepatitis B Virus Studies (2 publications)
  • Hepatitis C Virus Research (2 publications)
  • Liver Disease Diagnosis and Treatment (2 publications)
  • Infection Control and Ventilation (2 publications)
  • COVID-19 and Healthcare Impacts (2 publications)
  • Climate Change and Health Impacts (2 publications)

Recent publications by Fumio Imazeki include:

  • "Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan," 2022, published in the Journal of Gastroenterology
  • "Practical approach to prevent COVID-19 infection at breast cancer screening," 2021, published in Breast Cancer

Their frequent co-authors comprise:

  • Kazumasa Sakamoto
  • Kiyoaki Ito
  • Hiroshi Yotsuyanagi
  • Hiroshi Yatsuhashi
  • Yasuhito Tanaka

Fumio Imazeki's publications have appeared primarily in the following venues:

  • Journal of Gastroenterology
  • Breast Cancer

Best Publications

  • Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

    Haruhiko Yoshida;Yasushi Shiratori;Mitsuhiko Moriyama;Yasuyuki Arakawa

  • Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

    Yasushi Shiratori;Fumio Imazeki;Mitsuhiko Moriyama;Michitami Yano

  • Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

    Hajime Sumi;Osamu Yokosuka;Naohiko Seki;Makoto Arai

  • Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients

    Susumu Takano;Osamu Yokosuka;Fumio Imazeki;Masami Tagawa

  • Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival

    Yasushi Shiratori;Yoichi Ito;Osamu Yokosuka;Fumio Imazeki

  • Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

    Y Shiratori;N Kato;O Yokosuka;F Imazeki

  • Resolution of acute hepatitis C after therapy with natural beta interferon.

    M. Omata;O. Yokosuka;S. Takano;N. Kato

  • Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease

    Hiroshige Kojima;Osamu Yokosuka;Fumio Imazeki;Hiromitsu Saisho

  • Bezafibrate treatment: a new medical approach for PBC patients?

    Tatsuo Kanda;Osamu Yokosuka;Fumio Imazeki;Hiromitsu Saisho

  • Precore mutations and core clustering mutations in chronic hepatitis B virus infection

    Wan-Long Chuang;Masao Omata;Toshiki Ehata;Osamu Yokosuka

  • High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease

    F Tanaka;Y Shiratori;O Yokosuka;F Imazeki

  • Heterogeneity and evolution rates of delta virus RNA sequences.

    F Imazeki;M Omata;M Ohto

  • New antiviral therapies for chronic hepatitis C.

    Tatsuo Kanda;Fumio Imazeki;Osamu Yokosuka

  • Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA

    Osamu Yokosuka;Osamu Yokosuka;Masao Omata;Masao Omata;Fumio Imazeki;Fumio Imazeki;Kunio Okuda;Kunio Okuda

  • Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients

    Fumio Imazeki;Osamu Yokosuka;Kenichi Fukai;Tatsuo Kanda

  • Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma.

    Motohisa Tada;Fumihiko Kanai;Yasuo Tanaka;Keisuke Tateishi

  • Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

    Fumio Imazeki;Osamu Yokosuka;Kenichi Fukai;Hiromitsu Saisho

  • Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan.

    T Imamura;O Yokosuka;T Kurihara;T Kanda

  • Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.

    Tetsuhiro Chiba;Osamu Yokosuka;Kenichi Fukai;Hiroshige Kojima

  • Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells

    Tetsuhiro Chiba;Osamu Yokosuka;Makoto Arai;Motohisa Tada

  • Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis

    Keiichi Fujiwara;Osamu Yokosuka;Kenichi Fukai;Fumio Imazeki

  • 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells

    Tetsuhiro Chiba;Eiichiro Suzuki;Masamitsu Negishi;Atsunori Saraya

Frequent Co-Authors

Osamu Yokosuka
Osamu Yokosuka Chiba University
Hiromitsu Saisho
Hiromitsu Saisho Chiba University
Masao Omata
Masao Omata University of Tokyo
Kunio Okuda
Kunio Okuda Chiba University
Yasushi Shiratori
Yasushi Shiratori Okayama University
Michio Sata
Michio Sata Kurume University
Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Haruhiko Yoshida
Haruhiko Yoshida University of Tokyo
Eiji Tanaka
Eiji Tanaka Shinshu University
Naohiko Seki
Naohiko Seki Chiba University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related career paths, especially within healthcare and information management. For those interested in combining clinical knowledge with holistic health approaches, exploring how to become a functional medicine nurse practitioner can be a rewarding option. This role blends medical expertise with alternative practices to improve patient outcomes.

On the administrative side, expertise in medical coding and health information is increasingly valuable. Certification like the cpc certification salary highlights the earning potential and career growth possible in professional coding, which supports accurate medical billing and data management.

Those interested in managing healthcare data might consider careers in health information management. The health information management salary entry-level provides insight into starting salaries and growth opportunities in this vital field.

To help prepare for these roles, pursuing the best online health information management degree cahiim accredited can offer a flexible and reputable pathway. This accreditation ensures programs meet industry standards, making graduates more competitive in the job market.

Best Scientists Citing Fumio Imazeki

Trending Scientists

Recently Published Articles